1
Nov
2022

LMP LLC

Exhibitor at CPHI Frankfurt 2022 stand 40H32, Finished Dosage Formulations
About Us

LMP is a pharmaceutical manufacturing company, which develops, manufactures and sells niche generic finished dosage forms for topical applications which are used in dermatology, pain management etc. Currently the company main focus is on API permethrin containing topical formulations for scabies treatment. Company is present on pharmaceutical market in more than 10 countries e.g. Baltics, Netherlands, Poland, Ukraine etc.

  • LV
  • 2018
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 40H32, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2022

  • Permethrin LMP 50 mg/g gel

    Product Permethrin LMP 50 mg/g gel

    Safe and effective topical insecticide and acaricide that is intended for the treatment of scabies infestation